The APOLLOE4 Study is testing an investigational drug
to find out whether it may slow the progression of Alzheimer’s disease. At this
time there are no approved drugs that halt or arrest the clinical decline
typical of Alzheimer’s disease. The study drug is an oral tablet that is taken twice
daily with food. It has been well tolerated in earlier studies and may be a
convenient option for Alzheimer’s patients. If you have early symptoms of
Alzheimer’s disease, you may qualify for the APOLLOE4 Study. The study may be
right for you if you’re struggling with memory loss and find everyday tasks
more difficult. To learn more about the clinical research study and to see if
you may qualify, please visit the study website at APOLLOE4.com
Condition | Early Alzheimer's Disease, Alzheimer's Disease |
---|---|
Treatment | Placebo Comparator: Placebo, Experimental: ALZ-801 |
Clinical Study Identifier | NCT04770220 |
Sponsor | Alzheon Inc. |
Last Modified on | 20 September 2022 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.